MSB 2.08% 94.0¢ mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-269

  1. 226 Posts.
    lightbulb Created with Sketch. 113
    Agree with your comments. I know lots of us would love to say as it is , but sure the most of what the vast majority of us can say, yes, we are shareholders and have a financial interest, think and even believe that the product is for the betterment of humanity and superior to any alternatives that exist (including the one the law firm with questionable ethics, but loving money trying to protect no to lose a couple of billions), the pub test says that if it is used under another fancy name in Japan for over 4 years and they are paying for it that either the Japanese do not know what they are doing or extremely lucky or......... the bloody things work, some other countries like our Kiwi and also Canadian bros approved it and we also would love it here in Oz and FDA approval would help us to convince our TGA. So if you care about your kids under 12 where nothing is approved presently hence no hope for them, don't worry about the Disallowed, but use your common sense. A mate for you from Down Under.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.